Mechanism of Jiaotai Pills in treatment of depression based on quantitative proteomics.
10.19540/j.cnki.cjcmm.20230815.702
- Author:
Guo-Liang DAI
1
;
Bing-Ting SUN
2
;
Ze-Yu CHEN
3
;
Pei-Yao CHEN
1
;
Zhi-Tao JIANG
4
;
Wen-Zheng JU
1
Author Information
1. Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China.
2. Department of Pharmacy, Nanjing Hospital of Traditional Chinese Medicine Nanjing 210022, China.
3. School of Pharmacy, Xuzhou Medical University Xuzhou 221004, China.
4. Department of Pharmacy, Zhangjiagang Hospital of Traditional Chinese Medicine Suzhou 215600, China.
- Publication Type:Journal Article
- Keywords:
Jiaotai Pills;
depression;
proteomics;
rat
- MeSH:
Rats;
Animals;
Rats, Sprague-Dawley;
Depression/drug therapy*;
AMP-Activated Protein Kinases/metabolism*;
Proteomics;
Hippocampus;
Stress, Psychological/metabolism*;
Sphingolipids/metabolism*;
Disease Models, Animal;
Drugs, Chinese Herbal
- From:
China Journal of Chinese Materia Medica
2023;48(23):6500-6508
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to investigate the effect of Jiaotai Pills on protein expression in the hippocampus of the rat model of chronic unpredictable mild stress(CUMS)-induced depression by quantitative proteomics and explore the anti-depression mechanism of Jiaotai Pills. The SD rats were randomized into control, model, Jiaotai Pills, and fluoxetine groups(n=8). Other groups except the control group were subjected to CUMS modeling for 4 weeks. After 4 weeks of continuous administration, the changes of behavior and pathological morphology of the hippocampal tissue were observed. Proteins were extracted from the hippocampal tissue, and bioinformatics analysis was performed for the differentially expressed proteins(DEPs) identified by quantitative proteomics. Western blot was employed to verify the key DEPs. The results showed that Jiaotai Pills significantly alleviated the depression behaviors and hippocampal histopathological changes in the rat model of CUMS-induced depression. A total of 5 412 proteins were identified in the hippocampus of rats, including 65 DEPs between the control group and the model group and 35 DEPs between the Jiaotai Pills group and the model group. There were 16 DEPs with the same trend in the Jiaotai Pills group and the control group, which were mainly involved in sphingolipid, AMPK, and dopaminergic synapse signaling pathways. The Western blot results of Ppp2r2b, Cers1, and Ndufv3 in the hippocampus were consistent with the results of proteomics. In conclusion, Jiaotai Pills may play an anti-depression role by modulating the levels of Ppp2r2b, Cers1, Ndufv3 and other proteins and regulating sphingolipid, AMPK, and dopaminergic synapse signaling pathways.
